Cargando…
Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness
PURPOSE: To investigate the role of serum inflammatory cytokines and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and evaluate their relationship with macular thickness measurements obtained with optical coherence tomography (OCT). METHODS: The study enrolled 28 healthy sub...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751798/ https://www.ncbi.nlm.nih.gov/pubmed/19784389 |
_version_ | 1782172262924812288 |
---|---|
author | Ozturk, Banu Turgut Bozkurt, Banu Kerimoglu, Hurkan Okka, Mehmet Kamis, Umit Gunduz, Kemal |
author_facet | Ozturk, Banu Turgut Bozkurt, Banu Kerimoglu, Hurkan Okka, Mehmet Kamis, Umit Gunduz, Kemal |
author_sort | Ozturk, Banu Turgut |
collection | PubMed |
description | PURPOSE: To investigate the role of serum inflammatory cytokines and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and evaluate their relationship with macular thickness measurements obtained with optical coherence tomography (OCT). METHODS: The study enrolled 28 healthy subjects (Group 1), 31 patients without DR (Group 2), 49 patients with nonproliferative DR (Group 3), and 46 patients with proliferative DR (Group 4). Macular profile was assessed with Stratus OCT-3 and the serum concentrations of VEGF and interleukin-1α (IL-1α), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein (MCP-1), and epidermal growth factor (EGF) were measured using multiplex bead immunoassay. RESULTS: The median value of the visual acuity was 20/20 (Groups 1 and 2), and 20/100 (Group 3), and 20/125 (Group 4). The median value of central subfield macular thickness was estimated as 165.50 μm in Group 1, 202.5 μm in Group 2, 318 μm in Group 3, and 310 μm in Group 4. The median serum VEGF level, which was 98.20 pg/ml in Group 1, demonstrated a progressive rise to 125.37 pg/ml in Group 2, to 153.07 pg/ml in Group 3, and to 149.12 pg/ml in Group 4. Statistical significance was found between all groups (p<0.05) except between Groups 3 and 4 (p=0.87). The median levels of IL-1α and IL-6 were zero in all groups. The median serum levels of IL-8, IL-10, MIP-1α, and EGF revealed a wide range within each group but no statistical significance between the groups (p>0.05). The median serum levels of IL-8, IL-10, MIP-1α, and EGF revealed a wide range within each group, however, no statistically significant relationship was found between the groups (p>0.05). The median values of the serum MCP-1 concentrations presented a statistically significant rise with the progression of DR (p=0.02). No correlation was found between macular thickness and serum cytokine and VEGF levels (p>0.05). CONCLUSIONS: Increased serum levels of VEGF and MCP-1 may act as a key regulator of DR and provide a potential tool for risk assessment in diabetic patients. Further studies that evaluate both vitreous and serum levels in various stages of DR are needed to provide a better understanding of the interaction between systemic and local inflammatory and angiogenic factors. |
format | Text |
id | pubmed-2751798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-27517982009-09-25 Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness Ozturk, Banu Turgut Bozkurt, Banu Kerimoglu, Hurkan Okka, Mehmet Kamis, Umit Gunduz, Kemal Mol Vis Research Article PURPOSE: To investigate the role of serum inflammatory cytokines and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and evaluate their relationship with macular thickness measurements obtained with optical coherence tomography (OCT). METHODS: The study enrolled 28 healthy subjects (Group 1), 31 patients without DR (Group 2), 49 patients with nonproliferative DR (Group 3), and 46 patients with proliferative DR (Group 4). Macular profile was assessed with Stratus OCT-3 and the serum concentrations of VEGF and interleukin-1α (IL-1α), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein (MCP-1), and epidermal growth factor (EGF) were measured using multiplex bead immunoassay. RESULTS: The median value of the visual acuity was 20/20 (Groups 1 and 2), and 20/100 (Group 3), and 20/125 (Group 4). The median value of central subfield macular thickness was estimated as 165.50 μm in Group 1, 202.5 μm in Group 2, 318 μm in Group 3, and 310 μm in Group 4. The median serum VEGF level, which was 98.20 pg/ml in Group 1, demonstrated a progressive rise to 125.37 pg/ml in Group 2, to 153.07 pg/ml in Group 3, and to 149.12 pg/ml in Group 4. Statistical significance was found between all groups (p<0.05) except between Groups 3 and 4 (p=0.87). The median levels of IL-1α and IL-6 were zero in all groups. The median serum levels of IL-8, IL-10, MIP-1α, and EGF revealed a wide range within each group but no statistical significance between the groups (p>0.05). The median serum levels of IL-8, IL-10, MIP-1α, and EGF revealed a wide range within each group, however, no statistically significant relationship was found between the groups (p>0.05). The median values of the serum MCP-1 concentrations presented a statistically significant rise with the progression of DR (p=0.02). No correlation was found between macular thickness and serum cytokine and VEGF levels (p>0.05). CONCLUSIONS: Increased serum levels of VEGF and MCP-1 may act as a key regulator of DR and provide a potential tool for risk assessment in diabetic patients. Further studies that evaluate both vitreous and serum levels in various stages of DR are needed to provide a better understanding of the interaction between systemic and local inflammatory and angiogenic factors. Molecular Vision 2009-09-19 /pmc/articles/PMC2751798/ /pubmed/19784389 Text en http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ozturk, Banu Turgut Bozkurt, Banu Kerimoglu, Hurkan Okka, Mehmet Kamis, Umit Gunduz, Kemal Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title_full | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title_fullStr | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title_full_unstemmed | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title_short | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness |
title_sort | effect of serum cytokines and vegf levels on diabetic retinopathy and macular thickness |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751798/ https://www.ncbi.nlm.nih.gov/pubmed/19784389 |
work_keys_str_mv | AT ozturkbanuturgut effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness AT bozkurtbanu effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness AT kerimogluhurkan effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness AT okkamehmet effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness AT kamisumit effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness AT gunduzkemal effectofserumcytokinesandvegflevelsondiabeticretinopathyandmacularthickness |